cbdMD CEO Martin Sumichrast Steps Down Martin Sumichrast has resigned as CEO and member of the board of directors of cbdMD, Inc. (AMEX:YCBD) (AMEX:YCBDpA). Benzinga · Jun 13, 2022
EU's Food Safety Authority Validates cbdMD's Hemp Extract Formulation cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), has received validation of its novel food application from the European Union's Food Safety Authority for its hemp extract formulation. Benzinga · Apr 19, 2022
cbdMD And GNC Partnership Expanded With 11 More CBD Products Like Gummies, Sleep Aids, And Softgels cbdMD, Inc. (NYSE: YCBD) has expanded in product offerings online and in over 840 retail GNC Holdings, LLC stores nationwide. Benzinga · Mar 3, 2022
INDYCAR Driver & NASCAR Champion Jimmie Johnson Joins cbdMD As Brand Ambassador cbdMD, Inc. (NYSE: YCBD) (NYSE: YCBDPA) has entered into an endorsement agreement with 7-time NASCAR Cup Series (NCS) Champion and current NTT INDYCAR SERIES driver Jimmie Johnson as a strategic brand ambassador in the marketplace Benzinga · Feb 25, 2022
CbdMD Requests FDA Remove Drug Exclusion For CBD And Examine Its Safety Submission Natural Products Association filed a Citizen's Petition on cbdMD's (NYSE: YCBD) behalf with the Food and Drug Administration (FDA) requesting it remove the drug exclusion for CBD and review the company's extensive dossier of identity, safety and quality data. Benzinga · Feb 22, 2022
cbdMD Products Reach UK, Company Gets Validation By The UK Food Standards Agency For Its CBD Formulation cbdMD, Inc. (NYSE:YCBD) received validation of its Novel Food application from the United Kingdom's Food Standards Agency for its natural plant-based CBD formulation. Benzinga · Feb 17, 2022
cbdMD's Return On Capital Employed Overview Benzinga Pro data, cbdMD (AMEX:YCBD) reported Q1 sales of $9.32 million. Earnings fell to a loss of $19.16 million, resulting in a 533.19% decrease from last quarter. Benzinga · Feb 14, 2022
Recap: cbdMD Q1 Earnings cbdMD (AMEX:YCBD) reported its Q1 earnings results on Thursday, February 10, 2022 at 04:10 PM. Here's what investors need to know about the announcement. Earnings cbdMD missed estimated earnings by 300.0%, reporting an EPS of $-0.08 versus an estimate of $-0.02. Benzinga · Feb 10, 2022